top of page

EMA updated Guidance: IDMP Products Management Services - Implementation Guide

On 8 July 2022, EMA updated its Products Management Services - Implementation Guide "Implementation of International Organization for Standardization (ISO) standards for the Identification of Medicinal Products (IDMP) in Europe"


The International Organisation for Standardisation (ISO) Identification of Medicinal Products (IDMP) standards specify the use of standardised definitions for the identification and description of medicinal products for human use.

These provisions mandate EU member states (MSs), marketing authorisation holders (MAHs) and the European Medicines Agency (EMA) to use ISO IDMP standards for the exchange and communication of information on medicinal products.



The EU IDMP Implementation Guide (EU IG) for the submission of data on medicinal products defines the implementation requirements of the ISO IDMP standards and will be the basis for submission and exchange of medicinal product data in the EU.


SUMMARY OF CHANGES

In June 2021, the content of sections 2 and Chapter 3 of the EU Implementation Guide (IG) was amended to include information relevant to the publication of version 2.1.1 of the EU Implementation Guide (IG) documents. A portion of the information related to the publication of version 1 of the documents has been removed, while information related to versions 2.0 and 2.1 has been retained.


CLICK this LINK to know more about EU Implementation Guide.


Also to understand the recent updated Chapter 2: Data elements for the electronic submission of information on medicinal products for human use Click HERE and to understand Chapter 8 – Practical examples Click HERE


I Sometimes Send Newsletters

Thanks for submitting!

  • LinkedIn
  • Facebook
  • Twitter
  • Instagram

DISCLAIMER

The views expressed in this publication do not necessarily reflect the views of any guidance of government, health authority, it's purely my understanding. This Blog/Web Site is made available by a regulatory professional, is for educational purposes only as well as to give you general information and a general understanding of the pharmaceutical regulations, and not to provide specific regulatory advice. By using this blog site you understand that there is no client relationship between you and the Blog/Web Site publisher. The Blog/Web Site should not be used as a substitute for competent pharma regulatory advice and you should discuss from an authenticated regulatory professional in your state.  We have made every reasonable effort to present accurate information on our website; however, we are not responsible for any of the results you experience while visiting our website and request to use official websites.

bottom of page